Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies

Clinical trial NCT03722186 · SUSPENDED

Trial details

NCT number: NCT03722186
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Physiological Effects of Drugs Neoplasms by Histologic Type Lymphoma Hematologic Neoplasms Immunotherapy Advanced Cancer

Start date: 2018-11-13
Primary completion: 2019-04-04
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.